Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
29 Nov, 2022, 05.22 PM IST
Fosun Said to Mull Sale of India’s $3.6 Billion Gland PharmaA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
29 Nov, 2022, 04.53 PM IST
Gland Pharma rallies 9% as Fosun mulls selling controlling stake in firmA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
29 Nov, 2022, 03.24 PM IST
Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEOGland Pharma reported revenues of Rs 3463 and a net profit of Rs 997 crore in FY21. Shares of Gland Pharma rose 1.89% to close at Rs 3360 o...
10 Mar, 2022, 06.30 PM IST
74% Chinese-owned Hyderabad pharma firm files for IPOThe fresh issue and the offer for sale together is expected to take the IPO size to around Rs 3,000 crore.
12 Jul, 2020, 10.23 AM IST
Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 croreThe company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.
10 Jul, 2020, 10.19 PM IST
Fosun invests 800 crore in realty venture with Ahuja ConstructionsDeal is the first realty transaction in the country by a Chinese group
20 Sep, 2019, 06.25 AM IST
China’s Fosun shifts focus on early-stage startups in IndiaThe investor, which has made a mix of mid-to-late-stage and public equity investments in India, has built a team to focus on early-stage st...
14 Jun, 2018, 06.48 AM IST
Fosun targets Fortis: A white knight or a dark horse?Often known as China's Warren Buffett, Guo Guangchang prefers to be his student instead. His mysterious disappearance last year raised many...
18 Apr, 2018, 02.52 PM IST
China’s Fosun eyes stake in Ahuja ConstructionsThe Fosun Group is amongst China’s largest privately-owned investment conglomerates with interests spanning across pharmaceuticals, real es...
08 Mar, 2018, 08.08 AM IST
Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 billionFosun Pharma and Fosun International indirectly hold approximately 74 per cent equity interest in Gland Pharma, the joint statement added.
04 Oct, 2017, 06.58 PM IST
Doklam effect? India said to block Fosun's $1.3 billion Gland purchaseThe companies haven’t been formally notified yet of the move, the people said, asking not to be identified because the information is priva...
01 Aug, 2017, 04.00 PM IST
Gland Pharma's deal with Fosun will open up new markets: Ravi Penmetsa, MD, Gland PharmaThe deal with Fosun is also an example of the excellence of India’s manufacturing capabilities. It goes with the essence of the Make in Ind...
01 Aug, 2016, 09.00 AM IST
Fosun agrees to buy KKR-backed Gland Pharma for $1.4 billion: SourceThe deal would be the first major move by the Fosun group since Guo Guangchang, founder of flagship holding firm Fosun International Ltd an...
29 Jul, 2016, 06.09 AM IST
China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billionShanghai Fosun will acquire the shares held by Gland Pharma founders Ravi Penmetsa and his family and PE giant KKR.
28 Jul, 2016, 12.49 AM IST
China's Fosun to buy KKR backed Gland Pharma for $1.4 billionFosun has agreed to acquire 96 percent stake, which includes shares held by founders of Gland Pharma Ravi Penmetsa and family and private e...
27 Jul, 2016, 10.37 AM IST
Fosun leads the race to buy Gland Pharma with $1.27 billion bidComing from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-l...
06 Jun, 2016, 01.25 AM IST